Evidence for anterograde transport and transcytosis of botulinum neurotoxin A (BoNT/A)

J Neurosci. 2011 Nov 2;31(44):15650-9. doi: 10.1523/JNEUROSCI.2618-11.2011.

Abstract

Botulinum neurotoxin type A (BoNT/A) is a metalloprotease that blocks synaptic transmission via the cleavage of SNAP-25 (synaptosomal-associated protein of 25 kDa). BoNT/A is successfully used in clinical neurology for the treatment of several neuromuscular pathologies and pain syndromes. Despite its widespread use, relatively little is known on BoNT/A intracellular trafficking in neurons. Using the visual pathway as a model system, here we show that catalytically active BoNT/A is capable of undergoing anterograde axonal transport and transcytosis. Following BoNT/A injection into the rat eye, significant levels of BoNT/A-cleaved SNAP-25 appeared in the retinorecipient layers of the superior colliculus (SC). Anterograde propagation of BoNT/A effects required axonal transport, ruling out a systemic spread of the toxin. Cleaved SNAP-25 was present in presynaptic structures of the tectum, but retinal terminals were devoid of the immunoreactivity, indicative of transcytosis. Experiments based on sequential administration of BoNT/A and BoNT/E showed a persistent catalytic activity of BoNT/A in tectal cells following its injection into the retina. Our findings demonstrate that catalytically active BoNT/A is anterogradely transported from the eye to the SC and transcytosed to tectal synapses. These data are important for a more complete understanding of the mechanisms of action of BoNT/A.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biological Transport / drug effects
  • Botulinum Toxins / administration & dosage
  • Botulinum Toxins / pharmacokinetics*
  • Botulinum Toxins, Type A / pharmacology*
  • CD11b Antigen / metabolism
  • Dose-Response Relationship, Drug
  • Excitatory Amino Acid Agonists / toxicity
  • Functional Laterality / drug effects
  • Glial Fibrillary Acidic Protein / metabolism
  • Injections, Intraocular / methods
  • Kainic Acid / toxicity
  • Nerve Tissue Proteins / drug effects
  • Nerve Tissue Proteins / metabolism*
  • Neurotoxins / pharmacology*
  • Phosphopyruvate Hydratase / metabolism
  • Rats
  • Rats, Long-Evans
  • Superior Colliculi / drug effects
  • Superior Colliculi / metabolism
  • Synaptosomal-Associated Protein 25 / drug effects
  • Synaptosomal-Associated Protein 25 / metabolism
  • Time Factors
  • Transcytosis / drug effects*
  • Vesicular Glutamate Transport Protein 1 / metabolism
  • Vesicular Glutamate Transport Protein 2 / metabolism
  • Visual Pathways / drug effects*
  • Visual Pathways / injuries
  • Visual Pathways / metabolism

Substances

  • CD11b Antigen
  • Excitatory Amino Acid Agonists
  • Glial Fibrillary Acidic Protein
  • Nerve Tissue Proteins
  • Neurotoxins
  • Slc17a6 protein, rat
  • Slc17a7 protein, rat
  • Snap25 protein, rat
  • Synaptosomal-Associated Protein 25
  • Vesicular Glutamate Transport Protein 1
  • Vesicular Glutamate Transport Protein 2
  • Botulinum Toxins
  • Botulinum Toxins, Type A
  • Phosphopyruvate Hydratase
  • Kainic Acid
  • botulinum toxin type E